Form 8-K - Current report:
SEC Accession No. 0001104659-13-069265
Filing Date
2013-09-11
Accepted
2013-09-11 16:15:27
Documents
3
Period of Report
2013-09-10
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a13-20541_18k.htm 8-K 26395
2 EX-99.1 a13-20541_1ex99d1.htm EX-99.1 40527
3 GRAPHIC g205411mmi001.jpg GRAPHIC 4475
  Complete submission text file 0001104659-13-069265.txt   74164
Mailing Address
Business Address 45 HARTWELL AVE LEXINGTON MA 02421 781-274-8200
SYNTA PHARMACEUTICALS CORP (Filer) CIK: 0001157601 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33277 | Film No.: 131091227
SIC: 2834 Pharmaceutical Preparations